Respirology. 2016 Feb;21(2):259-68. doi: 10.1111/resp.12674. Epub 2015 Nov 13.
PMID:26564810
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network.
Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun.
PMID:37230499
Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP).
Ebner L, Christodoulidis S, Stathopoulou T, Geiser T, Stalder O, Limacher A, Heverhagen JT, Mougiakakou SG, Christe A.
PLoS One. 2020 Jan 13;15(1):e0226084. doi: 10.1371/journal.pone.0226084. eCollection 2020.
PMID:31929532
Nonspecific interstitial pneumonia.
Flaherty KR, Martinez FJ.
Semin Respir Crit Care Med. 2006 Dec;27(6):652-8. doi: 10.1055/s-2006-957336.
PMID:17195141
Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players.
Samarelli AV, Tonelli R, Marchioni A, Bruzzi G, Gozzi F, Andrisani D, Castaniere I, Manicardi L, Moretti A, Tabbì L, Cerri S, Beghè B, Dominici M, Clini E.
Int J Mol Sci. 2021 Aug 19;22(16):8952. doi: 10.3390/ijms22168952.